Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Animal Microbiome Analytics, Inc. is currently managing 2 pending office actions within the Chemistry & Materials technology area. These 2 pending office actions are distributed among 2 distinct examiners, which indicates that each active case is being evaluated by a different individual. This distribution means that the company prosecution experience is not concentrated under 1 official.
The busiest examiner for this portfolio is MERRIAM, ANDREW E, who is responsible for 1 pending office action. Since the total of 2 pending office actions is spread across 2 distinct examiners, MERRIAM, ANDREW E handles a portion of the workload that is equal to the other examiner involved. This creates a decentralized prosecution environment where the company must address the specific feedback of 2 different people.
The involvement of 2 distinct art units means that the technical review is conducted across different specialized groups at the patent office. With 2 distinct examiners and 2 distinct art units, the company must navigate various procedural preferences and technical standards. The company must tailor its responses to the specific requirements of the 2 distinct art units involved in the prosecution of these cases.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERRIAM, ANDREW E | 1 | 28.3% | +33.9% |
| BOWERS, ERIN M | 1 | 54.7% | +9.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19531099 | FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF | MERRIAM, ANDREW E | — |
| 19366131 | Products and Methods for Therapeutic Administration of Microorganisms to Non-Human Animals | BOWERS, ERIN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19531099 | FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF | MERRIAM, ANDREW E | — |
| Art Unit | Apps |
|---|---|
| 1791 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19531099 | FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF | MERRIAM, ANDREW E | 1791 | §102§103§112 | Final Rejection | — | Pending | Feb 05, 2026 |
| 19366131 | Products and Methods for Therapeutic Administration of Microorganisms to Non-Human Animals | BOWERS, ERIN M | 1653 | §103§112 | Final Rejection | — | Pending | Oct 22, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAnimal Microbiome Analytics, Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Andrew E Merriam has the most, with 1 of Animal Microbiome Analytics, Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
